Concepedia

Yuko Muramatsu

YM

Statistics

Publications

6

Citations

406

H-Index

6

Active since

1999

Affiliations

Astellas Pharma (Japan)(Current)

Fujisawa City Hospital

Yuko Muramatsu is an author at Astellas Pharma (Japan) specializing in life sciences, pharmacology, and neuroprotective agents.

Publications per year

1999–2014

6

Publications

6

SGLT2 selective inhibitor ipragliflozin reduces body fat mass by increasing fatty acid oxidation in high-fat diet-induced obese rats

Masanori Yokono, Toshiyuki Takasu, Yuka Hayashizaki et al. · European Journal of Pharmacology · 2014 · 194 citations · Full text

, , +10

Neuroprotective Efficacy of the Peroxisome Proliferator-Activated Receptor δ-Selective Agonists in Vitro and in Vivo

Akinori Iwashita, Yuko Muramatsu, Takao Yamazaki et al. · Journal of Pharmacology and Experimental Therapeutics · 2006 · 140 citations

, , +14

Neuroprotective efficacy of FR901459, a novel derivative of cyclosporin A, in in vitro mitochondrial damage and in vivo transient cerebral ischemia models

Yuko Muramatsu, Yasuhisa Furuichi, Nobuteru Tojo et al. · Brain Research · 2007 · 30 citations

, , +17

WF14861, a New Cathepsins B and L Inhibitor Produced by Colletotrichum sp. I. Taxonomy, Production, Purification and Structure lucidation.

TAKANAO OTSUKA, Yuko Muramatsu, Tomoji Higaki et al. · The Journal of Antibiotics · 1999 · 16 citations · Full text

, , +5

Novel neuroprotective compound SCH-20148 rescues thymocytes and SH-SY5Y cells from thapsigargin-induced mitochondrial membrane potential reduction and cell death

Yuko Muramatsu, Takuya Maemoto, Akinori Iwashita et al. · European Journal of Pharmacology · 2007 · 15 citations

, , +14

1–5 of 6